pubmed-article:3891896 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:3891896 | lifeskim:mentions | umls-concept:C0032098 | lld:lifeskim |
pubmed-article:3891896 | lifeskim:mentions | umls-concept:C0007585 | lld:lifeskim |
pubmed-article:3891896 | lifeskim:mentions | umls-concept:C0032172 | lld:lifeskim |
pubmed-article:3891896 | lifeskim:mentions | umls-concept:C1521827 | lld:lifeskim |
pubmed-article:3891896 | pubmed:issue | 4 | lld:pubmed |
pubmed-article:3891896 | pubmed:dateCreated | 1985-7-31 | lld:pubmed |
pubmed-article:3891896 | pubmed:abstractText | Incubation of photomixotrophic cell suspension cultures of rape (Brassica napus) and heterotrophic cell suspension cultures of soya (Glycine max) with 1-O-[1'-14C]hexadecyl-sn-glycerol or rac-1-O-[1'-14C]hexadecylglycerol leads in high yield (up to 78%) to labeled 1-O-hexadecyl-2-acyl-sn-glycero-3-phosphocholines. Alkaline hydrolysis of the choline glycerophospholipids yields pure 1-O-[1'-14C]hexadecyl-sn-glycero-3-phosphocholine. 1-O-[1'-14C]Hexadecyl-2-acetyl-sn-glycero-3-phosphocholine (platelet activating factor) is obtained by acetylating the lyso compound. The semi-synthetic preparation described leads to labeled platelet activating factor in an overall yield of 50-60% without loss of specific activity. | lld:pubmed |
pubmed-article:3891896 | pubmed:language | eng | lld:pubmed |
pubmed-article:3891896 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:3891896 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:3891896 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:3891896 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:3891896 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:3891896 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:3891896 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:3891896 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:3891896 | pubmed:month | Apr | lld:pubmed |
pubmed-article:3891896 | pubmed:issn | 0022-2275 | lld:pubmed |
pubmed-article:3891896 | pubmed:author | pubmed-author:WeberNN | lld:pubmed |
pubmed-article:3891896 | pubmed:author | pubmed-author:MangoldH KHK | lld:pubmed |
pubmed-article:3891896 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:3891896 | pubmed:volume | 26 | lld:pubmed |
pubmed-article:3891896 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:3891896 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:3891896 | pubmed:pagination | 495-500 | lld:pubmed |
pubmed-article:3891896 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
pubmed-article:3891896 | pubmed:meshHeading | pubmed-meshheading:3891896-... | lld:pubmed |
pubmed-article:3891896 | pubmed:meshHeading | pubmed-meshheading:3891896-... | lld:pubmed |
pubmed-article:3891896 | pubmed:meshHeading | pubmed-meshheading:3891896-... | lld:pubmed |
pubmed-article:3891896 | pubmed:meshHeading | pubmed-meshheading:3891896-... | lld:pubmed |
pubmed-article:3891896 | pubmed:meshHeading | pubmed-meshheading:3891896-... | lld:pubmed |
pubmed-article:3891896 | pubmed:meshHeading | pubmed-meshheading:3891896-... | lld:pubmed |
pubmed-article:3891896 | pubmed:meshHeading | pubmed-meshheading:3891896-... | lld:pubmed |
pubmed-article:3891896 | pubmed:meshHeading | pubmed-meshheading:3891896-... | lld:pubmed |
pubmed-article:3891896 | pubmed:meshHeading | pubmed-meshheading:3891896-... | lld:pubmed |
pubmed-article:3891896 | pubmed:meshHeading | pubmed-meshheading:3891896-... | lld:pubmed |
pubmed-article:3891896 | pubmed:year | 1985 | lld:pubmed |
pubmed-article:3891896 | pubmed:articleTitle | Semi-synthetic preparation of 1-O-[1'-14C]hexadecyl-2-acetyl-sn-glycero-3-phosphocholine (platelet activating factor) using plant cell cultures. | lld:pubmed |
pubmed-article:3891896 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:3891896 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |